Growth Metrics

Scholar Rock Holding (SRRK) Operating Expenses (2017 - 2026)

Scholar Rock Holding's quarterly Operating Expenses came in at $102.0 million in Q1 2026, up 32.33% year-on-year from $77.1 million in Q1 2025, and up 11.01% quarter-over-quarter from $91.9 million in Q4 2025.

Scholar Rock Holding has reported Operating Expenses for 10 years, with the latest figure at $102.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Operating Expenses rose 32.33% year-over-year to $102.0 million; the trailing twelve-month figure through Mar 2026 stood at $409.6 million (up 51.29% YoY), and the FY2025 full-year result was $384.6 million, up 52.6% from the prior year.
  • Operating Expenses for Q1 2026 stood at $102.0 million, up from $91.9 million in the prior quarter.
  • The five-year high for Operating Expenses was $112.1 million in Q2 2025, with the low at $39.1 million in Q2 2023.
  • Average Operating Expenses over 5 years is $63.4 million, with a median of $58.4 million recorded in 2024.
  • Year-over-year, Operating Expenses fell 9.42% in 2023 and jumped 88.42% in 2025.
  • Tracing SRRK's Operating Expenses over 5 years: stood at $40.4 million in 2022, then climbed by 18.81% to $48.0 million in 2023, then soared by 44.4% to $69.4 million in 2024, then soared by 32.5% to $91.9 million in 2025, then grew by 11.01% to $102.0 million in 2026.
  • The last three Operating Expenses figures came in at $102.0 million (Q1 2026), $91.9 million (Q4 2025), and $103.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.97 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 4.33 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -138.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 15.76 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.85 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.82 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.96 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 898.54 Mn
10 Scholar Rock Holding 500.61 Mn 20.67 Mn - 102.02 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 102.02 Mn
Dec 31, 2025 91.90 Mn
Sep 30, 2025 103.55 Mn
Jun 30, 2025 112.11 Mn
Mar 31, 2025 77.09 Mn
Dec 31, 2024 69.36 Mn
Sep 30, 2024 64.78 Mn
Jun 30, 2024 59.50 Mn
Mar 31, 2024 58.42 Mn
Dec 31, 2023 48.03 Mn
Sep 30, 2023 43.67 Mn
Jun 30, 2023 39.08 Mn
Mar 31, 2023 40.51 Mn
Dec 31, 2022 40.43 Mn
Sep 30, 2022 43.86 Mn
Jun 30, 2022 43.15 Mn
Mar 31, 2022 40.13 Mn
Dec 31, 2021 39.41 Mn
Sep 30, 2021 42.54 Mn
Jun 30, 2021 34.87 Mn
Mar 31, 2021 31.92 Mn
Dec 31, 2020 29.54 Mn
Sep 30, 2020 26.66 Mn
Jun 30, 2020 23.36 Mn
Mar 31, 2020 22.72 Mn
Dec 31, 2019 19.92 Mn
Sep 30, 2019 21.88 Mn
Jun 30, 2019 18.43 Mn
Mar 31, 2019 14.81 Mn
Dec 31, 2018 15.56 Mn
Sep 30, 2018 11.23 Mn
Jun 30, 2018 14.88 Mn
Mar 31, 2018 9.02 Mn
Dec 31, 2017 8.46 Mn
Sep 30, 2017 5.94 Mn
Jun 30, 2017 5.89 Mn